20 related articles for article (PubMed ID: 2370805)
1. A review of the pharmacokinetics of M
Matera MG; Rinaldi B; Berardo C; Rinaldi M; Cazzola M
Expert Opin Drug Metab Toxicol; 2020 Feb; 16(2):143-148. PubMed ID: 31958237
[No Abstract] [Full Text] [Related]
2. A pharmacokinetic and pharmacodynamic study of intravenous pilocarpine in humans.
Tanzer JM; Kramer PA; Schulman P; Willard AK
J Dent Res; 1995 Dec; 74(12):1845-9. PubMed ID: 8600180
[TBL] [Abstract][Full Text] [Related]
3. Topical Delivery of Muscarinic Receptor Antagonists Prevents and Reverses Peripheral Neuropathy in Female Diabetic Mice.
Jolivalt CG; Frizzi KE; Han MM; Mota AJ; Guernsey LS; Kotra LP; Fernyhough P; Calcutt NA
J Pharmacol Exp Ther; 2020 Jul; 374(1):44-51. PubMed ID: 32327528
[TBL] [Abstract][Full Text] [Related]
4. Reduced nicotinic receptor function in sympathetic ganglia is responsible for the hypothermia in the acetylcholinesterase knockout mouse.
Sun M; Lee CJ; Shin HS
J Physiol; 2007 Feb; 578(Pt 3):751-64. PubMed ID: 17038428
[TBL] [Abstract][Full Text] [Related]
5. Deprivation of Na+, Ca2+ and Mg2+ from the extracellular solution increases cytosolic Ca2+ and stimulates catecholamine secretion from cultured bovine adrenal chromaffin cells.
Luxoro M; Nassar-Gentina V; Rojas E
Mol Cell Biochem; 1997 May; 170(1-2):65-73. PubMed ID: 9144319
[TBL] [Abstract][Full Text] [Related]
6. Ionic mechanisms involved in the regulation of insulin secretion by muscarinic agonists.
Bordin S; Boschero AC; Carneiro EM; Atwater I
J Membr Biol; 1995 Nov; 148(2):177-84. PubMed ID: 8606366
[TBL] [Abstract][Full Text] [Related]
7. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
Gillard M; Waelbroeck M; Christophe J
Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
[TBL] [Abstract][Full Text] [Related]
8. Affinities of muscarinic drugs for [3H]N-methylscopolamine (NMS) and [3H]oxotremorine (OXO) binding to a mixture of M1-M4 muscarinic receptors: use of NMS/OXO-M ratios to group compounds into potential agonist, partial agonist, and antagonist classes.
Sharif NA; Williams GW; DeSantis LM
Neurochem Res; 1995 Jun; 20(6):669-74. PubMed ID: 7566362
[TBL] [Abstract][Full Text] [Related]
9. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex.
Ehlert FJ; Jenden DJ
Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562
[TBL] [Abstract][Full Text] [Related]
10. Differential inhibition of [3H]-oxotremorine-M and [3H]-quinuclinidyl benzilate binding to muscarinic receptors in rat brain membranes with acetylcholinesterase inhibitors.
Lockhart B; Closier M; Howard K; Steward C; Lestage P
Naunyn Schmiedebergs Arch Pharmacol; 2001 Apr; 363(4):429-38. PubMed ID: 11330337
[TBL] [Abstract][Full Text] [Related]
11. Regulation of brain acetylcholine concentration by muscarinic receptors.
Sethy VH; Francis JW
J Pharmacol Exp Ther; 1988 Jul; 246(1):243-8. PubMed ID: 3392656
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of muscarinic cholinergic drugs as determined by ex vivo (3H)-oxotremorine-M binding.
Sethy VH; Francis JW
J Pharmacol Methods; 1990 Jul; 23(4):285-96. PubMed ID: 2370805
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
